CHENNAI: An IIT Madras-led international study has found that accounting for atmospheric air pollution could improve the simulation of extreme rainfall and urban flooding. The findings were published ...
Pancreatic cancer does not respond to most immunotherapies, but RAS inhibitors could alter tumors to make them more sensitive to a novel immunotherapeutic approach. In pancreatic tumors with RAS ...
A resident assistant (RA) can be the person students see when they get locked out, need help with a problem or want to hear about quiet hours. For freshman Saanvi Guda, her RA is also the person ...
The surgical robotics space has never been more competitive - with three large strategics vying for share in the soft tissue segment of the market. Medtronic recently secured regulatory clearance for ...
Residential Assistants United Rising (RAUR — a student group advocating for the unionization of Resident Assistants (RAs) at Stanford — received a union election date of Oct. 6 and 7 following a ...
Revolution Medicines recently made history with the approval of its RAS inhibitor Rasonque for advanced pancreatic cancer. But behind RevMed is an entire field of biotechs working to broaden the reach ...
An updated systematic review evaluating the efficacy and safety of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and coagonists among adults with overweight or obesity without diabetes found ...
The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one ...
The biotech revealed at ASCO that daraxonrasib doubled progression-free survival, a result that led a massive conference audience to rise to their feet in applause. (Darren Incorvaia) Following ...
The FDA approved daraxonrasib, the first targeted therapy for metastatic pancreatic adenocarcinoma, citing a survival benefit vs chemotherapy. The FDA approved daraxonrasib (Rasonque; Revolution ...
The FDA has approved the first RAS-targeted therapy for metastatic pancreatic cancer, offering a new treatment option for patients with previously treated disease. Daraxonrasib (Rasonque, Revolution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results